Exicure Inc
XCUR
View Detailed Chart
5.920USD
-0.170-2.79%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
37.73MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-2.79%
5 Days
-6.77%
1 Month
+41.63%
6 Months
-20.75%
Year to Date
-56.69%
1 Year
-68.29%
View Detailed Chart
TradingKey Stock Score of Exicure Inc
Currency: USD Updated: 2025-12-19Key Insights
Exicure Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 226/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend up.Despite strong stock market performance and technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Exicure Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Exicure Inc Highlights
StrengthsRisks
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
Growing
The company is in a growing phase, with the latest annual income totaling USD 500.00K.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 500.00K.
Fairly Valued
The company’s latest PE is -1.59, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 828.16K shares, increasing 33.65% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 42.04K shares of this stock.
Exicure Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Exicure Inc Info
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
Ticker SymbolXCUR
CompanyExicure Inc
CEOYoo (Andy)
Websitehttps://www.exicuretx.com/
FAQs
What is the current price of Exicure Inc (XCUR)?
The current price of Exicure Inc (XCUR) is 5.920.
What is the symbol of Exicure Inc?
The ticker symbol of Exicure Inc is XCUR.
What is the 52-week high of Exicure Inc?
The 52-week high of Exicure Inc is 22.990.
What is the 52-week low of Exicure Inc?
The 52-week low of Exicure Inc is 3.101.
What is the market capitalization of Exicure Inc?
The market capitalization of Exicure Inc is 37.73M.
What is the net income of Exicure Inc?
The net income of Exicure Inc is -9.70M.
Is Exicure Inc (XCUR) currently rated as Buy, Hold, or Sell?
According to analysts, Exicure Inc (XCUR) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Exicure Inc (XCUR)?
The Earnings Per Share (EPS TTM) of Exicure Inc (XCUR) is -3.716.
Related Instruments
+1.32%
-0.88%
+1.75%
+0.83%
+0.60%
+0.38%
+0.91%
+1.03%
+2.32%
+0.60%
+0.40%
+1.97%
+1.63%
+1.21%
+0.65%
+0.66%
+2.57%
0.00%
-0.44%
+1.06%
